Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM RID=""ID="" Abbreviations: HI, Human insulin; MI, monomeric insulin; NEFA, non-esterified fatty acid; HGO, hepatic glucose production rate; β -OH-butyrate, β -hydroxy-butyrate; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus. | Zendy

AI Assistant Blog Pricing

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM RID=""ID="" Abbreviations: HI, Human insulin; MI, monomeric insulin; NEFA, non-esterified fatty acid; HGO, hepatic glucose production rate; β -OH-butyrate, β -hydroxy-butyrate; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.